Characterization of Fluoroquinolone-Resistant and Multidrug-Resistant Mycobacterium tuberculosis Isolates Using Whole-Genome Sequencing in Tianjin, China

References

• World Health Organization. Global Tuberculosis Report 2021. Licence: CC BY-NC-SA 3.0 IGO. Geneva: World Health Organization;2021.
   Google Scholar
• Avalos E, Catanzaro D, Catanzaro A, et al. Frequency and geographic distribution of gyrA and gyrB mutations associated with fluoroquinolone resistance in clinical Mycobacterium tuberculosis isolates: a systematic review. PLoS One. 2015;10(3):e0120470. doi:10.1371/journal.pone.0120470
   PubMed Web of Science ®Google Scholar
• Cao Y, Parmar H, Gaur RL, et al. Xpert MTB/XDR: a 10-color reflex assay suitable for point-of-care settings to detect isoniazid, fluoroquinolone, and second-line-injectable-drug resistance directly from Mycobacterium tuberculosis-positive sputum. J ClinMicrobiol. 2021;59(3):e02314–20. doi:10.1128/JCM.02314-20
   Web of Science ®Google Scholar
• Lee EH, Yong SH, Leem AY, et al. Improved fluoroquinolone-resistant and extensively drug-resistant tuberculosis treatment outcomes. Open Forum Infect Dis. 2019;6(4):ofz118. doi:10.1093/ofid/ofz118
   Web of Science ®Google Scholar
• Zong K, Luo C, Zhou H, et al. Xpert MTB/RIF assay for the diagnosis of rifampicin resistance in different regions: a meta-analysis. BMC Microbiol. 2019;19(1):177. doi:10.1186/s12866-019-1516-5
   Web of Science ®Google Scholar
• Deelder W, Christakoudi S, Phelan J, et al. Machine learning predicts accurately Mycobacterium tuberculosis Drug resistance from whole genome sequencing data. Front Genet. 2019;10:922. doi:10.3389/fgene.2019.00922
   PubMed Web of Science ®Google Scholar
• Köser CU, Bryant JM, Becq J, et al. Whole-genome sequencing for rapid susceptibility testing of M. tuberculosis. N Engl J Med. 2013;369(3):290–292. doi:10.1056/NEJMc1215305
   PubMed Web of Science ®Google Scholar
• Maruri F, Guo Y, Blackman A, et al. Resistance-conferring mutations on whole-genome sequencing of fluoroquinolone-resistant and -susceptible Mycobacterium tuberculosis isolates: a proposed threshold for identifying resistance. Clin Infect Dis. 2021;72(11):1910–1918. doi:10.1093/cid/ciaa496
   Web of Science ®Google Scholar
• Papaventsis D, Casali N, Kontsevaya I, et al. Whole genome sequencing of Mycobacterium tuberculosis for detection of drug resistance: a systematic review. Clin MicrobiolInfect. 2017;23(2):61–68. doi:10.1016/j.cmi.2016.09.008
   Web of Science ®Google Scholar
• Zaw MT, Emran NA, Lin Z. Mutations inside rifampicin-resistance determining region of rpoB gene associated with rifampicin-resistance in Mycobacterium tuberculosis. J Infect Public Health. 2018;11(5):605–610. doi:10.1016/j.jiph.2018.04.005
   PubMed Web of Science ®Google Scholar
• Seifert M, Catanzaro D, Catanzaro A, et al. Genetic mutations associated with isoniazid resistance in Mycobacterium tuberculosis: a systematic review. PLoS One. 2015;10(3):e0119628. doi:10.1371/journal.pone.0119628
   PubMed Web of Science ®Google Scholar
• Sekiguchi J, Miyoshi-Akiyama T, Augustynowicz-Kopeć E, et al. Detection of multidrug resistance in Mycobacterium tuberculosis. J Clin Microbiol. 2007;45(1):179–192. doi:10.1128/JCM.00750-06
   Web of Science ®Google Scholar
• Bwalya P, Yamaguchi T, Solo ES, et al. Characterization of mutations associated with streptomycin resistance in multidrug-resistant Mycobacterium tuberculosis in Zambia. Antibiotics. 2021;10(10):1169. doi:10.3390/antibiotics10101169
   Web of Science ®Google Scholar
• Tam KK, Leung KS, Siu GK, et al. Direct detection of pyrazinamide resistance in Mycobacterium tuberculosis by use of pncA PCR sequencing. J ClinMicrobiol. 2019;57(8):e00145–19. doi:10.1128/JCM.00145-19
   Web of Science ®Google Scholar
• Charoenpak R, Santimaleeworagun W, Suwanpimolkul G, et al. Association between the phenotype and genotype of isoniazid resistance among Mycobacterium tuberculosis isolates in Thailand. Infect Drug Resist. 2020;13:627–634. doi:10.2147/IDR.S242261
   Web of Science ®Google Scholar
• Chernyaeva EN, Shulgina MV, Rotkevich MS, et al. Genome-wide Mycobacterium tuberculosis variation (GMTV) database: a new tool for integrating sequence variations and epidemiology. BMC Genomics. 2014;15:308. doi:10.1186/1471-2164-15-308.
   PubMed Web of Science ®Google Scholar
• World Health Organization.The Use of Next-Generation Sequencing Technologies for the Detection of Mutations Associated with Drug Resistance in Mycobacterium Tuberculosis Complex: TechnicalGuide. World Health Organization; 2018.
   Google Scholar
• Brossier F, Sougakoff W, Bernard C, et al. Molecular analysis of the embCAB locus and embR gene involved in ethambutol resistance in clinical isolates of Mycobacterium tuberculosis in France. Antimicrob Agents Chemother. 2015;59(8):4800–4808. doi:10.1128/AAC.00150-15
   PubMed Web of Science ®Google Scholar
• Andres S, Gröschel MI, Hillemann D, et al. A diagnostic algorithm to investigate pyrazinamide and ethambutol resistance in rifampin-resistant Mycobacterium tuberculosis isolates in a low-incidence setting. Antimicrob Agents Chemother. 2019;63(2):e01798–18. doi:10.1128/AAC.01798-18
   Web of Science ®Google Scholar
• Ramaswamy SV, Amin AG, Göksel S, et al. Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2000;44(2):326–336. doi:10.1128/AAC.44.2.326-336.2000
   PubMed Web of Science ®Google Scholar
• Luo M, Li K, Zhang H, et al. Molecular characterization of para-aminosalicylic acid resistant Mycobacterium tuberculosis clinical isolates in southwestern China. Infect Drug Resist. 2019;12:2269–2275. doi:10.2147/IDR.S207259
   PubMed Web of Science ®Google Scholar
• Barbier M, Wirth T. The evolutionary history, demography, and spread of the Mycobacterium tuberculosis complex. MicrobiolSpectr. 2016;4(4):53. doi:10.1128/microbiolspec.TBTB2-0008-2016
   Google Scholar
• Rigouts L, Miotto P, Schats M, et al. Fluoroquinolone heteroresistance in Mycobacterium tuberculosis: detection by genotypic and phenotypic assays in experimentally mixed populations. Sci Rep. 2019;9(1):11760. doi:10.1038/s41598-019-48289-9
   PubMed Web of Science ®Google Scholar
• Georghiou SB, Magana M, Garfein RS, et al. Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review. PLoS One. 2012;7(3):e33275. doi:10.1371/journal.pone.0033275
   PubMed Web of Science ®Google Scholar
• Rahman A, Ferdous SS, Ahmed S, et al. Pyrazinamide susceptibility and pncA mutation profiles of Mycobacterium tuberculosis among multidrug-resistant tuberculosis patients in Bangladesh. Antimicrob Agents Chemother. 2017;61(9):e00511–17. doi:10.1128/AAC.00511-17
   Web of Science ®Google Scholar
• Khan MT, Malik SI, Ali S, et al. Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan. BMC Infect Dis. 2019;19(1):116. doi:10.1186/s12879-019-3764-2
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang J, Cui P, et al. Identification of novel efflux proteins Rv0191, Rv3756c, Rv3008, and Rv1667c involved in pyrazinamide resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2017;61(8):e00940–17. doi:10.1128/AAC.00940-17
   Web of Science ®Google Scholar
• Tan Y, Su B, Zheng H, et al. Molecular characterization of prothionamide-resistant Mycobacterium tuberculosis isolates in Southern China. Front Microbiol. 2017;8:2358. doi:10.3389/fmicb.2017.02358
   Web of Science ®Google Scholar
• Fenner L, Egger M, Bodmer T, et al. Effect of mutation and genetic background on drug resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2012;56(6):3047–3053. doi:10.1128/AAC.06460-11
   Web of Science ®Google Scholar
• Goossens SN, Sampson SL, Van Rie A. Mechanisms of drug-induced tolerance in Mycobacterium tuberculosis. ClinMicrobiolRev. 2020;34(1):e00141-20. doi:10.1128/CMR.00141-20
   Web of Science ®Google Scholar
• Jajou R, van der Laan T, de Zwaan R, et al. WGS more accurately predicts susceptibility of Mycobacterium tuberculosis to first-line drugs than phenotypic testing. J AntimicrobChemother. 2019;74(9):2605–2616. doi:10.1093/jac/dkz215
   Web of Science ®Google Scholar